NeuroOne Medical Technologies Corporation announced the formation of a six member advisory board of leading neurosurgeons to assist in the completion of development of a radio frequency ablation electrode intended to record and ablate brain tissue linked to causing seizure activity. The six members that have been appointed to the advisory board are as follows: Dr. Daniel Couture, Wake Forest Baptist Health; Dr. Gerald Grant, Stanford University Medical Center; Dr. Bob Gross, Emory University; Dr. Zachary Levine, Holy Cross Health, George Washington University; Dr. Guy McKhann, New York Presbyterian Hospital, Columbia University; and Dr. Jamie Van Gompel, Mayo Clinic.